OR WAIT null SECS
December 22, 2023
Article
The seismic shifts in mentality for allergy management and the strides made in immunotherapy have kept parents of children with allergies hopeful, but changes are still needed.
December 19, 2023
The decision by the FDA is a step closer to omalizumab’s potential approval, making it the potential first medicine to reduce reactions to many different food allergens after accidental exposure.
November 16, 2023
Video
During this segment of his interview, Dr. Kim went into the Harmony study data on safety of ADP101 presented at ACAAI as well as the implications of the research.
In this interview segment, Dr. Kim described some of the background and importance of the Harmony study data presented at ACAAI for patients with food allergy.
October 10, 2023
This new recommendation by the European Academy of Allergy and Clinical Immunology was put forward to help guide clinical practices.
October 08, 2023
Data show how care providers shifted their mindsets to prioritize efficacy, safety, tolerability and availability factors during the 2022 formula supply shortage and recall crises.
October 05, 2023
This new analysis was described as the first estimate on the prevalence in Europe of specific TNA and sensitization.
September 26, 2023
The agency’s guideline updates were announced, with the overall goal being to help food facilities in their adherence to current good manufacturing practices.
September 11, 2023
This research shows that a basophil activation test can support decision-making by clinicians when re-introduction of baked eggs in patients with allergies is a treatment being considered.
August 25, 2023
This analysis on a larger study population led to results which add useful data to the growing literature on sesame thresholds and may even help to assess sesame safe doses used in risk management.